Quest Diagnostics awards Mark Delaney 2,615 restricted stock units
DGX•Quest Diagnostics awarded Chief Commercial Officer Mark E. Delaney 2,615 shares of common stock on Nov. 3, 2026. He directly held 12,975 shares following the award.
DGX•DGX•DGX•Quest Diagnostics awarded Chief Commercial Officer Mark E. Delaney 2,615 shares of common stock on Nov. 3, 2026. He directly held 12,975 shares following the award.
Quest Diagnostics awarded Chief Commercial Officer Mark E. Delaney 2,615 shares of common stock on Nov. 3, 2026. Delaney directly held 12,975 shares following the award.
